DK4387730T3 - Faste former af en rock-hæmmer - Google Patents

Faste former af en rock-hæmmer

Info

Publication number
DK4387730T3
DK4387730T3 DK23776436.0T DK23776436T DK4387730T3 DK 4387730 T3 DK4387730 T3 DK 4387730T3 DK 23776436 T DK23776436 T DK 23776436T DK 4387730 T3 DK4387730 T3 DK 4387730T3
Authority
DK
Denmark
Prior art keywords
solid forms
rock inhibitor
rock
inhibitor
solid
Prior art date
Application number
DK23776436.0T
Other languages
English (en)
Inventor
Andrew Belfield
Clifford D Jones
Richard Armer
Original Assignee
Redx Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2213103.1A external-priority patent/GB202213103D0/en
Priority claimed from GBGB2214708.6A external-priority patent/GB202214708D0/en
Application filed by Redx Pharma Ltd filed Critical Redx Pharma Ltd
Application granted granted Critical
Publication of DK4387730T3 publication Critical patent/DK4387730T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK23776436.0T 2022-09-08 2023-09-08 Faste former af en rock-hæmmer DK4387730T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2213103.1A GB202213103D0 (en) 2022-09-08 2022-09-08 Crystalline form of a rock inhibitor
GBGB2214708.6A GB202214708D0 (en) 2022-10-06 2022-10-06 Crystalline form of a rock inhibitor
PCT/GB2023/052341 WO2024052704A1 (en) 2022-09-08 2023-09-08 Solid forms of a rock inhibitor

Publications (1)

Publication Number Publication Date
DK4387730T3 true DK4387730T3 (da) 2025-09-01

Family

ID=88188945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK23776436.0T DK4387730T3 (da) 2022-09-08 2023-09-08 Faste former af en rock-hæmmer

Country Status (20)

Country Link
US (1) US20260078108A1 (da)
EP (2) EP4387730B1 (da)
JP (2) JP2024534810A (da)
KR (1) KR20250057882A (da)
CN (1) CN119894884A (da)
AU (1) AU2023336823A1 (da)
CA (1) CA3262882A1 (da)
DK (1) DK4387730T3 (da)
ES (1) ES3040251T3 (da)
FI (1) FI4387730T3 (da)
HR (1) HRP20251018T1 (da)
HU (1) HUE073310T2 (da)
IL (1) IL319110A (da)
LT (1) LT4387730T (da)
MX (1) MX2025002776A (da)
PL (1) PL4387730T3 (da)
PT (1) PT4387730T (da)
SI (1) SI4387730T1 (da)
SM (1) SMT202500313T1 (da)
WO (1) WO2024052704A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202403179D0 (en) 2024-03-05 2024-04-17 Redx Pharma Plc Method of making kinase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60115077T2 (de) * 2000-09-29 2006-06-29 Bristol-Myers Squibb Co. Dynamische trennung von isomeren und getrennte isomere
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
JP2014525425A (ja) * 2011-08-31 2014-09-29 アマケン エンヴェー 新規のｒｏｃｋキナーゼ阻害剤
SMT201700317T1 (it) * 2013-01-29 2017-09-07 Redx Pharma Plc Derivati piridinici in qualità di inibitori rock teneri
US9562121B2 (en) * 2013-02-12 2017-02-07 National University Corporation Kanazawa University Optically active poly(diphenylacetylene) compound, preparation method therefor, and use thereof as optical isomer separating agent
KR102720461B1 (ko) * 2016-01-22 2024-10-21 잔센파마슈티카엔.브이. Nik 억제제로서의 신규 6원 헤테로방향족 치환된 시아노인돌린 유도체
AU2018241940B2 (en) * 2017-04-01 2023-09-28 Adeptio Pharmaceuticals Limited Dihydrotetrabenazine for use in the treatment a movement disorder
JP7576581B2 (ja) * 2019-06-27 2024-10-31 バイオジェン・エムエイ・インコーポレイテッド イミダゾ［１，２－ａ］ピリジニル誘導体及び疾患の処置におけるそれらの使用

Also Published As

Publication number Publication date
IL319110A (en) 2025-04-01
US20260078108A1 (en) 2026-03-19
PL4387730T3 (pl) 2025-09-22
JP2025090729A (ja) 2025-06-17
PT4387730T (pt) 2025-08-27
KR20250057882A (ko) 2025-04-29
CA3262882A1 (en) 2024-03-14
LT4387730T (lt) 2025-09-10
JP2024534810A (ja) 2024-09-26
ES3040251T3 (en) 2025-10-29
WO2024052704A1 (en) 2024-03-14
CN119894884A (zh) 2025-04-25
EP4520746A3 (en) 2025-06-04
EP4387730A1 (en) 2024-06-26
MX2025002776A (es) 2025-04-02
EP4387730B1 (en) 2025-05-28
HUE073310T2 (hu) 2026-01-28
HRP20251018T1 (hr) 2025-10-24
SMT202500313T1 (it) 2025-09-12
EP4520746A2 (en) 2025-03-12
AU2023336823A1 (en) 2025-02-20
FI4387730T3 (fi) 2025-08-25
SI4387730T1 (sl) 2025-10-30

Similar Documents

Publication Publication Date Title
DK4214202T3 (da) Faste former af en cdk4-hæmmer
LT3880670T (lt) Pagrindinio tarpinio kras g12c inhibitoriaus junginio patobulinta sintezė
IL284226A (en) Novel polymorphic forms of a tgfb inhibitor
EP4495113A4 (en) KIF18A INHIBITOR
EP3984999A4 (en) ALLOSTERIC INHIBITOR OF PHOSPHATASE SHP2
DK3972960T3 (da) Krystallinske former af en btk-hæmmer
DK4058453T3 (da) Forbedret syntese af kras g12c-inhibitorforbindelse
EP4332103A4 (en) ATR INHIBITOR COMPOUND CONTAINING A SULFOXIMINE
EP4434979A4 (en) KIF18A INHIBITOR
IL315027A (en) Inhibitors of nlrp3
EP3901156A4 (en) NITROOXY DERIVATIVE OF ROCK KINASE INHIBITOR
DK3826982T3 (da) Anvendelse af en substitueret thiazolidinforbindelse som nitrificeringshæmmer
DK3894012T3 (da) Krystallinske former og saltformer af en kinasehæmmer
DK4114826T3 (da) Krystallinske former af en farmaceutisk forbindelse
IL304497A (en) Crystalline forms of a pyrrolopyridine-aniline compound
ECSP22016209A (es) Síntesis de un inhibidor de calicreína plasmática a escala de proceso
IL314221A (en) Synthesis of a kif18a inhibitor
DK4387730T3 (da) Faste former af en rock-hæmmer
DK4288036T3 (da) Formuleringer af en plasmakallikreinhæmmer
EP4168398A4 (en) TYK-2 INHIBITOR
PL4126862T3 (pl) Sposób wytwarzania związku będącego inhibitorem cot
DK3974774T3 (da) Opmåling af byggegrube
JP1791593S (ja) 一組の家具セット
EP4257795C0 (en) ANCHOR BOLT
EP3919493A4 (en) CRYSTAL OF A DIARYLTHIOHYDANTOIN COMPOUND